English
简体中文
Total: £ 56.28
Published Date: 2025-05-28 | Pages: 98 | Tables: 94 | Pharma & Healthcare
The global market for Peptide Therapeutics Drugs was valued at US$ 41210 million in the year 2024 and is projected to reach a revised size of US$ 74720 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Peptide therapeutic drugs are a class of pharmaceutical compounds composed of short chains of amino acids (peptides) that mimic or influence biological processes. These drugs are designed to interact with specific receptors or enzymes in the body, offering high selectivity and efficacy with relatively low toxicity. Due to their ability to closely replicate natural biological molecules, peptide drugs play a critical role in regulating functions such as hormone signaling, immune responses, and metabolic processes.
The Peptide Therapeutics Drugs market is primarily driven by the growing demand for targeted and effective treatments across a range of diseases, including cancer, metabolic disorders, and infectious diseases. Peptides offer several advantages over traditional small molecule drugs, such as high specificity, low toxicity, and better biocompatibility. Advances in peptide synthesis technologies, drug delivery systems, and formulation methods have significantly improved their stability and bioavailability, further enhancing their therapeutic potential. Additionally, the rising prevalence of chronic diseases and increasing investment in biotechnology and pharmaceutical R&D are fueling the development and approval of novel peptide-based drugs, driving market expansion globally.
Despite their promising therapeutic benefits, peptide drugs face key challenges that hinder their broader adoption. One major limitation is their poor oral bioavailability, as peptides are easily degraded by enzymes in the gastrointestinal tract, often requiring alternative routes of administration like injections. Moreover, peptides can have short half-lives, necessitating frequent dosing or advanced delivery technologies to maintain efficacy. High production costs and complex manufacturing processes also pose barriers, particularly for large-scale commercialization. Addressing these challenges through innovative drug design, formulation strategies, and cost-effective manufacturing solutions is essential to unlock the full potential of peptide therapeutics.
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics Drugs.
The Peptide Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Aurinia Pharmaceuticals
BioMarin Pharmaceutical
Apellis Pharmaceuticals
Lantheus
CSL Vifor Group
Segment by Type
Injection
Oral
Other
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Drugs Market Perspective (2020-2031)
2.2 Global Peptide Therapeutics Drugs Growth Trends by Region
2.2.1 Global Peptide Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Therapeutics Drugs Historic Market Size by Region (2020-2025)
2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Region (2026-2031)
2.3 Peptide Therapeutics Drugs Market Dynamics
2.3.1 Peptide Therapeutics Drugs Industry Trends
2.3.2 Peptide Therapeutics Drugs Market Drivers
2.3.3 Peptide Therapeutics Drugs Market Challenges
2.3.4 Peptide Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Drugs Players by Revenue
3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2020-2025)
3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide Therapeutics Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Therapeutics Drugs Revenue
3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2024
3.5 Global Key Players of Peptide Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Peptide Therapeutics Drugs, Product and Application
3.7 Global Key Players of Peptide Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Therapeutics Drugs Breakdown Data by Type
4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2020-2025)
4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2026-2031)
5 Peptide Therapeutics Drugs Breakdown Data by Application
5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2020-2025)
5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Therapeutics Drugs Market Size (2020-2031)
6.2 North America Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Therapeutics Drugs Market Size by Country (2020-2025)
6.4 North America Peptide Therapeutics Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Therapeutics Drugs Market Size (2020-2031)
7.2 Europe Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Therapeutics Drugs Market Size by Country (2020-2025)
7.4 Europe Peptide Therapeutics Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2020-2031)
8.2 Asia-Pacific Peptide Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Therapeutics Drugs Market Size (2020-2031)
9.2 Latin America Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Therapeutics Drugs Market Size by Country (2020-2025)
9.4 Latin America Peptide Therapeutics Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2020-2031)
10.2 Middle East & Africa Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide Therapeutics Drugs Introduction
11.2.4 Teva Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Drugs Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide Therapeutics Drugs Introduction
11.5.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide Therapeutics Drugs Introduction
11.6.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide Therapeutics Drugs Introduction
11.7.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide Therapeutics Drugs Introduction
11.8.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide Therapeutics Drugs Introduction
11.9.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide Therapeutics Drugs Introduction
11.10.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide Therapeutics Drugs Introduction
11.11.4 Merck Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide Therapeutics Drugs Introduction
11.12.4 The Medicines Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Peptide Therapeutics Drugs Introduction
11.13.4 J & J Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.13.5 J & J Recent Development
11.14 Aurinia Pharmaceuticals
11.14.1 Aurinia Pharmaceuticals Company Details
11.14.2 Aurinia Pharmaceuticals Business Overview
11.14.3 Aurinia Pharmaceuticals Peptide Therapeutics Drugs Introduction
11.14.4 Aurinia Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.14.5 Aurinia Pharmaceuticals Recent Development
11.15 BioMarin Pharmaceutical
11.15.1 BioMarin Pharmaceutical Company Details
11.15.2 BioMarin Pharmaceutical Business Overview
11.15.3 BioMarin Pharmaceutical Peptide Therapeutics Drugs Introduction
11.15.4 BioMarin Pharmaceutical Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.15.5 BioMarin Pharmaceutical Recent Development
11.16 Apellis Pharmaceuticals
11.16.1 Apellis Pharmaceuticals Company Details
11.16.2 Apellis Pharmaceuticals Business Overview
11.16.3 Apellis Pharmaceuticals Peptide Therapeutics Drugs Introduction
11.16.4 Apellis Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.16.5 Apellis Pharmaceuticals Recent Development
11.17 Lantheus
11.17.1 Lantheus Company Details
11.17.2 Lantheus Business Overview
11.17.3 Lantheus Peptide Therapeutics Drugs Introduction
11.17.4 Lantheus Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.17.5 Lantheus Recent Development
11.18 CSL Vifor Group
11.18.1 CSL Vifor Group Company Details
11.18.2 CSL Vifor Group Business Overview
11.18.3 CSL Vifor Group Peptide Therapeutics Drugs Introduction
11.18.4 CSL Vifor Group Revenue in Peptide Therapeutics Drugs Business (2020-2025)
11.18.5 CSL Vifor Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Peptide Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Peptide Therapeutics Drugs Market Share by Region (2020-2025)
Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Peptide Therapeutics Drugs Market Share by Region (2026-2031)
Table 11. Peptide Therapeutics Drugs Market Trends
Table 12. Peptide Therapeutics Drugs Market Drivers
Table 13. Peptide Therapeutics Drugs Market Challenges
Table 14. Peptide Therapeutics Drugs Market Restraints
Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2020-2025)
Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2024)
Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Peptide Therapeutics Drugs, Headquarters and Area Served
Table 21. Global Key Players of Peptide Therapeutics Drugs, Product and Application
Table 22. Global Key Players of Peptide Therapeutics Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Peptide Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Sanofi Company Details
Table 48. Sanofi Business Overview
Table 49. Sanofi Peptide Therapeutics Drugs Product
Table 50. Sanofi Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Teva Company Details
Table 53. Teva Business Overview
Table 54. Teva Peptide Therapeutics Drugs Product
Table 55. Teva Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 56. Teva Recent Development
Table 57. Novo Nordisk Company Details
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Peptide Therapeutics Drugs Product
Table 60. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Takeda Company Details
Table 63. Takeda Business Overview
Table 64. Takeda Peptide Therapeutics Drugs Product
Table 65. Takeda Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Peptide Therapeutics Drugs Product
Table 70. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Peptide Therapeutics Drugs Product
Table 75. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Peptide Therapeutics Drugs Product
Table 80. Novartis Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. AbbVie Company Details
Table 83. AbbVie Business Overview
Table 84. AbbVie Peptide Therapeutics Drugs Product
Table 85. AbbVie Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Ipsen Company Details
Table 88. Ipsen Business Overview
Table 89. Ipsen Peptide Therapeutics Drugs Product
Table 90. Ipsen Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 91. Ipsen Recent Development
Table 92. Ferring Company Details
Table 93. Ferring Business Overview
Table 94. Ferring Peptide Therapeutics Drugs Product
Table 95. Ferring Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 96. Ferring Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Peptide Therapeutics Drugs Product
Table 100. Merck Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 101. Merck Recent Development
Table 102. The Medicines Company Details
Table 103. The Medicines Business Overview
Table 104. The Medicines Peptide Therapeutics Drugs Product
Table 105. The Medicines Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 106. The Medicines Recent Development
Table 107. J & J Company Details
Table 108. J & J Business Overview
Table 109. J & J Peptide Therapeutics Drugs Product
Table 110. J & J Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 111. J & J Recent Development
Table 112. Aurinia Pharmaceuticals Company Details
Table 113. Aurinia Pharmaceuticals Business Overview
Table 114. Aurinia Pharmaceuticals Peptide Therapeutics Drugs Product
Table 115. Aurinia Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 116. Aurinia Pharmaceuticals Recent Development
Table 117. BioMarin Pharmaceutical Company Details
Table 118. BioMarin Pharmaceutical Business Overview
Table 119. BioMarin Pharmaceutical Peptide Therapeutics Drugs Product
Table 120. BioMarin Pharmaceutical Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 121. BioMarin Pharmaceutical Recent Development
Table 122. Apellis Pharmaceuticals Company Details
Table 123. Apellis Pharmaceuticals Business Overview
Table 124. Apellis Pharmaceuticals Peptide Therapeutics Drugs Product
Table 125. Apellis Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 126. Apellis Pharmaceuticals Recent Development
Table 127. Lantheus Company Details
Table 128. Lantheus Business Overview
Table 129. Lantheus Peptide Therapeutics Drugs Product
Table 130. Lantheus Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 131. Lantheus Recent Development
Table 132. CSL Vifor Group Company Details
Table 133. CSL Vifor Group Business Overview
Table 134. CSL Vifor Group Peptide Therapeutics Drugs Product
Table 135. CSL Vifor Group Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 136. CSL Vifor Group Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report
List of Figures
Figure 1. Peptide Therapeutics Drugs Picture
Figure 2. Global Peptide Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Therapeutics Drugs Market Share by Type: 2024 VS 2031
Figure 4. Injection Features
Figure 5. Oral Features
Figure 6. Other Features
Figure 7. Global Peptide Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Peptide Therapeutics Drugs Market Share by Application: 2024 VS 2031
Figure 9. Cancer Case Studies
Figure 10. Metabolic Disorders Case Studies
Figure 11. Central Nervous System Case Studies
Figure 12. Other Case Studies
Figure 13. Peptide Therapeutics Drugs Report Years Considered
Figure 14. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Peptide Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Peptide Therapeutics Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Peptide Therapeutics Drugs Market Share by Players in 2024
Figure 18. Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2024
Figure 20. North America Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Peptide Therapeutics Drugs Market Share by Country (2020-2031)
Figure 22. United States Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Peptide Therapeutics Drugs Market Share by Country (2020-2031)
Figure 26. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2020-2031)
Figure 34. China Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Peptide Therapeutics Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 50. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 51. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 52. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 55. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 57. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 58. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 60. The Medicines Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 61. J & J Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 62. Aurinia Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 63. BioMarin Pharmaceutical Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 64. Apellis Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 65. Lantheus Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 66. CSL Vifor Group Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
